ClinicalTrials.govpublic full text
Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Combination With Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Recurrent or Metastatic Melanoma
recurrent melanoma, stage iv skin melanoma, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 908158
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.